Analysis shows cannabis may increase psychosis risk while offering therapeutic potential, suggesting harm reduction strategies.
Summary Cannabis use increases the risk of psychosis, but cannabis-based medicinal products may provide additional therapeutic opportunities. Decriminalisation of cannabis has led to wider availability in certain jurisdictions, while in the UK regulated medicinal preparations are not readily accessible. A more balanced approach could reduce harms while maximising potential therapeutic benefits.
No takes yet. Share an insight, caveat, or question.
Rashmi Patel (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: